SRDX - Surmodics, Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue73,11271,36661,898
Cost of Revenue11,42210,9088,619
Gross Profit61,69060,45853,279
Operating Expenses
Research Development31,81718,49816,165
Selling General and Administrative20,35119,49217,406
Non Recurring-3,1873,187
Total Operating Expenses-43,599-
Operating Income or Loss7,10316,85919,089
Income from Continuing Operations
Total Other Income/Expenses Net-7089-848
Earnings Before Interest and Taxes7,03316,94818,241
Interest Expense---
Income Before Tax7,03316,94818,241
Income Tax Expense3,1076,9636,294
Minority Interest---
Net Income From Continuing Ops3,9269,98511,947
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income3,9269,98511,947
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares3,9269,98511,947